|
NVIDIA starts 2025 by announcing a trio of partnerships and a research collaboration to boost healthcare sector presence.
|
 |
|
After selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a different entity, which will be owned by the biotech’s current shareholders.
|
|
|
The proposed deal comes soon after Sage implemented a restructuring plan to focus on Zurzuvae’s launch in postpartum depression.
|
|
|
Amgen CEO Robert Bradway said the company's obesity drug could find its space in the market due to once-monthly dosing and expansion of manufacturing capabilities.
|
|
|
The PDUFA action date for the more convenient autoinjector is set for August 2025.
|
|
|
US-based biotech Normunity plans to initiate a Phase I clinical trial of NRM-823 in the second half of 2025.
|
|
|
LEO Pharma is eligible to receive up to $1.7bn in total payments, which include a $250m upfront payment.
|
|
